BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2199 related articles for article (PubMed ID: 25750525)

  • 1. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of inspiratory capacity on dyspnea evaluation in COPD with or without emphysematous lesions: a pilot study.
    Cui L; Ji X; Xie M; Dou S; Wang W; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2823-2830. PubMed ID: 29033563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion capacity of the lung for carbon monoxide - A potential marker of impaired gas exchange or of systemic deconditioning in chronic obstructive lung disease?
    Weinreich UM; Thomsen LP; Brock C; Karbing DS; Rees SE
    Chron Respir Dis; 2015 Nov; 12(4):357-64. PubMed ID: 26323278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inspiratory capacity/total lung capacity ratio as a predictor of survival in an emphysematous phenotype of chronic obstructive pulmonary disease.
    French A; Balfe D; Mirocha JM; Falk JA; Mosenifar Z
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1305-12. PubMed ID: 26203237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pulmonary emphysema on COPD assessment test-oriented categorization in GOLD document.
    Suzuki T; Tada Y; Kawata N; Ikari J; Kasahara Y; Sakurai Y; Iesato K; Nishimura R; West J; Tatsumi K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1199-205. PubMed ID: 26150711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired carbon monoxide diffusing capacity is the strongest predictor of exercise intolerance in COPD.
    Farkhooy A; Janson C; Arnardóttir RH; Malinovschi A; Emtner M; Hedenström H
    COPD; 2013 Apr; 10(2):180-5. PubMed ID: 23547629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity.
    Harvey BG; Strulovici-Barel Y; Kaner RJ; Sanders A; Vincent TL; Mezey JG; Crystal RG
    Eur Respir J; 2015 Dec; 46(6):1589-1597. PubMed ID: 26541521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the desaturation-distance ratio from the six-minute walk test for patients with COPD.
    Fujimoto Y; Oki Y; Kaneko M; Sakai H; Misu S; Yamaguchi T; Mitani Y; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2669-2675. PubMed ID: 28919734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans.
    Kahnert K; Jobst B; Biertz F; Biederer J; Watz H; Huber RM; Behr J; Grenier PA; Alter P; Vogelmeier CF; Kauczor HU; Jörres RA
    Chron Respir Dis; 2019; 16():1479972318775423. PubMed ID: 29742906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.
    Shin TR; Oh YM; Park JH; Lee KS; Oh S; Kang DR; Sheen S; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Rhee CK; Choe KH; Lee JS; Lee SD
    J Korean Med Sci; 2015 Oct; 30(10):1459-65. PubMed ID: 26425043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobar analysis of collapsibility indices to assess functional lung volumes in COPD patients.
    Kitano M; Iwano S; Hashimoto N; Matsuo K; Hasegawa Y; Naganawa S
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1347-56. PubMed ID: 25525352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extent of emphysema in patients with COPD.
    Shaker SB; Stavngaard T; Hestad M; Bach KS; Tonnesen P; Dirksen A
    Clin Respir J; 2009 Jan; 3(1):15-21. PubMed ID: 20298367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the heterogeneity of COPD by V/P SPECT: a new tool for improving the diagnosis of parenchymal defects and grading the severity of small airways disease.
    Bajc M; Chen Y; Wang J; Li XY; Shen WM; Wang CZ; Huang H; Lindqvist A; He XY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1579-1587. PubMed ID: 28603413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
    Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
    Xie M; Wang W; Dou S; Cui L; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Mets OM; Schmidt M; de Koning HJ; Aalst Cv; Oudkerk M; Vliegenthart R; Ginneken Bv; van Rikxoort EM; Zanen P
    COPD; 2014 Sep; 11(5):503-9. PubMed ID: 25093696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 110.